vimarsana.com
Home
Live Updates
European Patent Office Approves Key Patent for Indaptus Therapeutics Platform Technology : vimarsana.com
European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biopharma company that utilizes a propr...
Related Keywords
United States ,
Jeffrey Meckler ,
Louie Toma ,
Jules Abraham ,
European Patent Office ,
Nasdaq ,
Indaptus Therapeutics Inc ,
Company Decoy ,
Infections Using Bacteria ,
Indaptus Therapeutics ,
Private Securities Litigation Reform ,
Quarterly Report ,
Annual Report ,
Relations Contact ,
vimarsana.com © 2020. All Rights Reserved.